Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics

ConditionCancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age70+
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle

About this trial

Oncogeriatric: a collaboration between oncologists and geriatricians which aims to ensure that all elderly cancer patients receive treatment adapted to their condition, thanks to a multidisciplinary and multi-professional approach.

This project aims to gain a better understanding of the motivational determinants of PA and nutrition in elderly cancer patients.

It has a dual objective:

1. to identify clusters/groups in patients on the basis of daily motivational factors focusing on PA and nutrition 2. on the basis of the results obtained in (1), to propose an interventional study based on the previously established clusters, in order to examine the effects of a behavioral intervention on patients' adherence to PA and nutrition, both agreed according to an individualized goal and defined in agreement with the patient and the multidisciplinary team, taking into account the recommendations.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient aged 70 or over

With cancer (solid tumors, all sites)

G8 ≤ 14

Inactive (patient not meeting recommended physical activity levels of 150 minutes per week at moderate intensity)

Disqualifiers

Known presence of brain metastases

Inability to participate in digital platform assessments or physical tests

Inability to eat orally

Contraindication or inability to engage in physical activity

Trial design

Design model

Single group

Treatments tested in this trial

  • Collecting the variables and Implementation of a behavioural intervention

    Behavioral

    The observational phase (during 15 days) * Two measurements per day for motivational variables and physical activity and nutrition * Two measurements per day for nutrition * Three measurements per day for fatigue * Continuous PA measurement by accelerometer The interventional phase : Part A (during 7 days) * measuring physical activity (PA) * complete questionnaires and numerical scales : * Motivational factors * Self-evaluation of nutrition * Self-assessment of fatigue Part B: BEHAVIORAL INTERVENTION (10 weeks),the APA teacher will call a patient once a week for follow-up. Answer questionnaires and scales on the digital platform will be done : * Motivational factors * Self-evaluation of nutrition * Self-assessment of fatigue Part C : End of interventional phase(during 7 days) * measuring physical activity * complete questionnaires and numerical scales : * Motivational factors * Self-evaluation of nutrition * Self-assessment of fatigue

Treatment groups

55 Participants
are divided into 1 treatment group
Group A: Observation phase and Intervention phaseExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

For observationnal phase : Identify relevant motivational levers in order to build a personalized and adapted behavioral intervention to improve physical activity and nutrition behaviors, via cluster analysis.

Clusters (groups of patients) evaluated by the "silhouette coefficient" and seprated by behavior, on one hand concerning Physical Activity (PA) and on the other hand concerning nutrition.

Time frame
from baseline at 15 days
2

For Interventionnal phase : Improving nutrition behaviors of elderly cancer patients

Quality of nutrition questionnaire (Ingestas)

Time frame
from baseline at 12 weeks
3

For Interventionnal phase : Improving physical activity behaviors of elderly cancer patients

Number of physical activities

Time frame
from baseline at 12 weeks

Secondary outcomes

1

Measure the population's adherence to a methodology using digital tools and data collection via EMA.

The proportion of participants with a data collection rate

Time frame
at 15 days and at 12 weeks
2

Study acceptance of participation in the study and reasons for refusal

Percentage of patients included vs total number of patients offered study

Time frame
at 15 days and at 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.